Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial.
Mukohara T, Park YH, Sommerhalder D, Yonemori K, Hamilton E, Kim SB, Kim JH, Iwata H, Yamashita T, Layman RM, Mita M, Clay T, Chae YS, Oakman C, Yan F, Kim GM, Im SA, Lindeman GJ, Rugo HS, Liyanage M, Saul M, Le Corre C, Skoura A, Liu L, Li M, LoRusso PM.
Mukohara T, et al. Among authors: liu l.
Nat Med. 2024 Jun 24. doi: 10.1038/s41591-024-03129-w. Online ahead of print.
Nat Med. 2024.
PMID: 38914862
No abstract available.